Faithward Advisors LLC Purchases 5,162 Shares of Marsh & McLennan Companies, Inc. $MRSH

Faithward Advisors LLC increased its position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 165.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,273 shares of the financial services provider’s stock after purchasing an additional 5,162 shares during the period. Faithward Advisors LLC’s holdings in Marsh & McLennan Companies were worth $1,435,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of MRSH. Numerai GP LLC lifted its holdings in shares of Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock valued at $7,501,000 after acquiring an additional 33,729 shares during the period. Swiss Life Asset Management Ltd increased its position in shares of Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after purchasing an additional 11,648 shares in the last quarter. Barclays PLC lifted its holdings in Marsh & McLennan Companies by 41.7% during the 3rd quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider’s stock valued at $443,844,000 after purchasing an additional 647,987 shares during the last quarter. Sarasin & Partners LLP boosted its position in Marsh & McLennan Companies by 0.9% in the fourth quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock valued at $173,411,000 after buying an additional 8,283 shares in the last quarter. Finally, CSM Advisors LLC bought a new stake in Marsh & McLennan Companies during the third quarter worth about $1,180,000. Institutional investors and hedge funds own 87.99% of the company’s stock.

Marsh & McLennan Companies Price Performance

Shares of Marsh & McLennan Companies stock opened at $164.09 on Wednesday. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $220.32. The company has a market capitalization of $79.27 billion, a P/E ratio of 20.51, a P/E/G ratio of 2.33 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.21 by $0.08. The firm had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. On average, analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.

Insider Activity

In related news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer owned 116,811 shares in the company, valued at $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Wells Fargo & Company cut their target price on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research note on Thursday, April 9th. Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target for the company in a report on Wednesday, May 6th. UBS Group reduced their price objective on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating on the stock in a research note on Tuesday, June 9th. Mizuho decreased their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating on the stock in a report on Monday, April 13th. Finally, Piper Sandler cut their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a report on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $200.19.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.